Katsu Ishida - Search Results

Year	Number of Results
2019	1
2020	1
2021	3
2022	1
2024	0

1

Characterization of false positive, contaminant-driven mutagenicity in impurities associated with the sotorasib drug substance.

Coppi A, Davies R, Wegesser T, Ishida K, Karmel J, Han J, Aiello F, Xie Y, Corbett MT, Parsons AT, Monticello TM, Minocherhomji S. Coppi A, et al. Among authors: ishida k. Regul Toxicol Pharmacol. 2022 Jun;131:105162. doi: 10.1016/j.yrtph.2022.105162. Epub 2022 Mar 21. Regul Toxicol Pharmacol. 2022. PMID: 35331777

2

Nonclinical Safety Profile of Sotorasib, a KRAS^G12C-Specific Covalent Inhibitor for the Treatment of KRAS p.G12C-Mutated Cancer.

Ishida K, Werner JA, Davies R, Fan F, Thomas B, Wahlstrom J, Lipford JR, Monticello T. Ishida K, et al. Int J Toxicol. 2021 Oct;40(5):427-441. doi: 10.1177/10915818211022965. Epub 2021 Jun 17. Int J Toxicol. 2021. PMID: 34137282

3

Phosphatidylinositol 3-Kinase δ-Specific Inhibitor-Induced Changes in the Ovary and Testis in the Sprague Dawley Rat and Cynomolgus Monkey.

Ishida K, Werner JA, Lafleur M, Wisler J, Wannberg S, Kalanzi J, Bussiere JL, Monticello TM. Ishida K, et al. Int J Toxicol. 2021 Jul-Aug;40(4):344-354. doi: 10.1177/10915818211008175. Epub 2021 Apr 19. Int J Toxicol. 2021. PMID: 33866838

4

Development of an ICOSL and BAFF bispecific inhibitor AMG 570 for systemic lupus erythematosus treatment.

Zhang M, Lee F, Knize A, Jacobsen F, Yu S, Ishida K, Miner K, Gaida K, Whoriskey J, Chen C, Gunasekaran K, Hsu H. Zhang M, et al. Among authors: ishida k. Clin Exp Rheumatol. 2019 Nov-Dec;37(6):906-914. Epub 2019 Feb 15. Clin Exp Rheumatol. 2019. PMID: 30789152 Free article.

5

Mercapturate pathway metabolites of sotorasib, a covalent inhibitor of KRAS^G12C, are associated with renal toxicity in the Sprague Dawley rat.

Werner JA, Davies R, Wahlstrom J, Dahal UP, Jiang M, Stauber J, David B, Siska W, Thomas B, Ishida K, Humphreys WG, Lipford JR, Monticello TM. Werner JA, et al. Among authors: ishida k. Toxicol Appl Pharmacol. 2021 Jul 15;423:115578. doi: 10.1016/j.taap.2021.115578. Epub 2021 May 15. Toxicol Appl Pharmacol. 2021. PMID: 34004237

6

Phosphatidylinositol 3-Kinase δ Inhibitor-Induced Immunomodulation and Secondary Opportunistic Infection in the Cynomolgus Monkey (Macaca fascicularis).

Werner JA, Ishida K, Wisler J, Karbowski C, Kalanzi J, Bussiere J, Monticello TM. Werner JA, et al. Among authors: ishida k. Toxicol Pathol. 2020 Dec;48(8):949-964. doi: 10.1177/0192623320966238. Epub 2020 Nov 28. Toxicol Pathol. 2020. PMID: 33252030

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

6 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year